AMBRA1 and breast cancer: AMBRA1 depletion potentiated the metastatic potential of breast cancer cells toward the bones and the lungs in vivo, indicating that the CUL4/AMBRA1-mediated SMAD4 ubiquitylation should be therapeutically investigated in TGF-β-dependent metastatic cancers.